Related Experiment Video
Updated: May 30, 2026

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice
Published on: May 5, 2022
Prognostic value of exercise-induced ventricular arrhythmia in Chagas' heart disease
Roberto Coury Pedrosa1, José Hugo Gameiro Salles, Monica M F Magnanini
1Hospital Universitário Clementino Fraga Filho, Federal University of Rio de Janeiro, Brazil. coury@hucff.ufrj.br
Insights
Exercise-induced ventricular arrhythmia (EIVA) is common in chronic Chagas heart disease. EIVA significantly increases cardiovascular death risk, especially in patients with cardiomegaly, aiding risk stratification.
Area of Science:
- Cardiology
- Tropical Medicine
- Epidemiology
Background:
- Chronic Chagas heart disease affects millions globally.
- Risk stratification for cardiovascular mortality is crucial in managing Chagas disease.
Purpose of the Study:
- To assess the prevalence of exercise-induced ventricular arrhythmia (EIVA) in chronic Chagas heart disease.
- To evaluate the prognostic significance of EIVA for cardiovascular mortality.
Main Methods:
- Prospective cohort study of 130 clinically stable Chagas disease patients.
- Follow-up for total cardiovascular mortality from 1990-2007.
- Kaplan-Meier survival analysis and Cox proportional hazard models were used.
Main Results:
- EIVA prevalence was 43.1% among participants.
- Cardiovascular deaths occurred in 25.4% of patients.
- EIVA showed a trend towards increased mortality (HR 1.84, P=0.09), significantly elevated in patients with cardiomegaly (4x risk, P=0.05).
Conclusions:
- EIVA is a prevalent finding in stable Chagas heart disease patients.
- EIVA serves as a significant marker for cardiovascular mortality, particularly in those with cardiomegaly.
- EIVA can be a valuable tool for risk stratification in this population.
Objective:
To determine the prevalence and the prognostic value of exercise-induced ventricular arrhythmia (EIVA) in chronic Chagas' heart disease.
Study Design And Setting:
An open prospective cohort of 130 clinically stable patients at a University Hospital outpatient unit in Rio de Janeiro, Brazil, was followed up at scheduled clinical visits from 1990 through 2007. The endpoint was total cardiovascular mortality. Survival curves (Kaplan-Meier) and a multivariate Cox proportional hazard model were adjusted to determine the association between EIVA and mortality.
Results:
The median duration of follow-up was 9.9 years (range, 132 days to 17 years). EIVA prevalence was 43.1% (95% CI: 34.5-51.7). Thirty-three cardiovascular deaths (25.4%) occurred. The hazard ratio of EIVA for cardiovascular death, after adjustment for age, was 1.84 (P = 0.09). An interaction was found between EIVA and cardiomegaly on x-ray. In the group with cardiomegaly, the hazard of dying was four times greater in the presence of EIVA (P for interaction = 0.05).
Conclusion:
In clinically stable chagasic subjects with cardiomegaly, EIVA is a clinically significant marker of total cardiovascular mortality and may be a useful risk stratification tool in this population.
Related Concept Videos
Dysrhythmias V: Evaluating Dysrhythmias
Cardiomyopathy III: Hypertrophic Cardiomyopathy
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy
